Development of a common priority list of pharmaceuticals relevant for the water cycle

Water Science and Technology

Volumn 59, Issue 1, 2009, Pages 39-46

  De Voogt, P ^a   Janex Habibi, M L ^b   Sacher, F ^c   Puijker, L ^a   Mons, M ^a  

^a KWR WATERCYCLE RESEARCH INSTITUTE   (Netherlands)

^b SUEZ Environment   (France)

^c DVGW Technologiezentrum Wasser   (Germany)

Author keywords

Pharmaceuticals; Priority setting

Indexed keywords

ANALYTICAL METHOD; HUMAN HEALTH; PHARMACEUTICALLY ACTIVE COMPOUNDS; POTENTIAL RISKS; PRESCRIPTION DRUGS; PRIORITIZATION; PRIORITY LIST; PRIORITY SETTING; SIGNIFICANT IMPACTS; VETERINARY DRUGS; WATER CYCLE; WATER RESEARCH;

WATER SUPPLY;

HEALTH RISKS;

DRUG; NON PRESCRIPTION DRUG; VETERINARY DRUG;

DRUG; ENVIRONMENTAL RISK; HEALTH RISK; MEDICINE; PUBLIC HEALTH; RISK FACTOR; WATER BUDGET; WATER SUPPLY;

ANALYTIC METHOD; ARTICLE; HEALTH HAZARD; METHODOLOGY; QUALITATIVE ANALYSIS; WASTE WATER MANAGEMENT; WATER SUPPLY; ANIMAL; CLASSIFICATION; ENVIRONMENTAL MONITORING; HUMAN; INDUSTRIAL WASTE; PUBLIC HEALTH; RISK ASSESSMENT; STANDARD; WATER POLLUTANT;

ANIMALS; ENVIRONMENTAL MONITORING; HUMANS; INDUSTRIAL WASTE; PHARMACEUTICAL PREPARATIONS; PUBLIC HEALTH; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 63649142301     PISSN: 02731223     EISSN: None     Source Type: Journal    
DOI: 10.2166/wst.2009.764     Document Type: Article

References (29)

1. AwwaRF 2006 Toxicological Relevance of Endocrine Disrupting Chemicals and Pharmaceuticals in Water. 5th periodic report. Study #3085. Henderson, NV, USA.
2. Besse, J. P. & Garric, J. 2007 Proposition d'une liste de médicaments à usage humain à surveiller dans les eaux de surface continentales. Cemagref, Lyon, France, pp. 1-241.
3. Besse, J. P., Garric, J. & Coquery, M. 2007 Implementation of a classification methodology to select human pharmaceuticals to survey in receiving aquatic ecosystems. SETAC Europe 17th Annual Meeting, Porto, Portugal TH014.
4. BLAC-Bericht: Arzneimittel in der Umwelt 2003 Bund/Länderausschuss für Chemikaliensicherheit, Hamburg, Germany:
5. California DHS 2006 Department of Health Services-pharmaceuticals list cited in AWWARF (2006).
6. Derksen, J. G. M., van Eeijnatten, G. M., Lahr, J., van der Linde, P. & Kroon, A. G. M. 2002 Environmental Effects of Human Pharmaceuticals. RIWA Association of river waterworks, Nieuwegein, The Netherlands, pp. 1-211.
7. European Parliament 2007 P6-TA-PROV(2007)0190. A6-0125/2007. European Parliament legislative resolution of 22 May 2007 amendment to Directive 2000/60/EC.
8. Grung, M., Källqvist, T., Langford, K. & Thomas, K. V. 2007 Environmental risk assessment of eleven pharmaceuticals according to the EMEA guidelines in Norway, SETAC Europe 17th Annual Meeting, Porto, Portugal TH020.
9. GWRC 2004 Pharmaceuticals and personal care products in the water cycle. An international review, London, UK.
10. Hekster, F. & Mons, M. 2004 Prioritaire geneesmiddelen voor waterbeheerders. ISBN 90.5773.258.0, STOWA.2004-W04.Utrecht, The Netherlands.
11. Hilton, M. J., Thomas, K. V. & Ashton, D. 2003 Targeted Monitoring Programme for Pharmaceuticals in the Aquatic Environment. Environment Agency, Bristol, UK, pp. 1-57.
12. Jones, O. A. H., Voulvoulis, N. & Lester, J. N. 2002 Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res. 36, 5013-5022.
13. KNAPPE project 2006 EU FP6 research project. Ecole des Mines, Alès, France. www.knappe-eu.org.
14. Knepper, T. P., Barcelo, D., Lindner, K., Seel, P., Reemtsma, T., Ventura, F., De Wever, H., van der Voet, E., Gehringer, P. & Schönerklee, M. 2004 Removal of persistent polar pollutants through improved treatment of. effluents (P-Three). Water Sci. Technol. 50, 195-202.
15. Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B. & Buxton, H. T. 2002 Pharmaceutical, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36(6), 1202-1211.
16. Kostich, M. S. & Lazorchak, J. M. 2008 Risks to aquatic organisms posed by human pharmaceutical use. Sci. Total Environ. 389, 329-339.
17. Kujawa-Roeleveld, K., Akanyeti, I., Mahmoud, N. & Shi, W. 2007 Sustainable water management in the city of the future (EU 018530-SWITCH): pharmaceutical compounds in environment, pre-selection. Wageningen University, Wageningen, the Netherlands.
18. Landesumweltamt Brandenburg 2002 Ökotoxikologische Bewertung von Humanarzneimitteln in aquatischen Ökosystemen. Priority setting based on (local) PEC/PNEC calculations. 180 S. 2002, Potsdam/Frankfurt (Oder) Germany.
19. Mons, M., van Genderen, J. & Hogenboom, A. 2004 Samenvatting informatie geneesmiddelen. BTO rapport 2004.004, Kiwa WR, Nieuwegein, The Netherlands.
20. Ongerth, J. E. & Khan, S. J. 2004 Drug residuals: how xenobiotics can affect water supply sources. J. Am. Water Works Assoc. 96(5), 94-101.
21. Park, J. 2005 Pharmaceuticals in the environment and management approaches in Korea. Korea Environment Institute, Seoul, Korea. And abstract SETAC Europe 17th Annual Meeting 2007, Porto, Portugal TH005. Full document was not available until recently; the abstract referring to this document did not provide the full list of prioritized PhAC in South Korea, and could therefore not be included in the present evaluation.
22. Pomati, F., Castiglioni, S., Zuccato, E., Fanelli, R., Vigetti, D., Rossetti, C. & Calamari, D. 2006 Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environ. Sci. Technol., 2442-2447.
23. Rohweder, U. 2003 Arzneimittel in der Umwelt-Auswertung der Untersuchungsergebnisse. Bund/Laenderausschuss fuer Chemicaliensicherheit-BLAC, Hamburg, Germany, pp. 1-171.
24. Schrap, S. M., Rijs, G. B. J., Beek, M. A., Maaskant, J. F. N., Staeb, J., Stroomberg, G. & Tiesnitsch, J. 2003 Humane en veterinaire geneesmiddelen in Nederlands oppervlaktewater en afvalwater. RIZA report 2003.023, Lelystad, The Netherlands.
25. Snyder, S. A., Wert, E. C., Lei, H., Westervoort, P. & Yoon, Y. 2007 Removal of EDCs and Pharmaceuticals in Drinking and Reuse Treatment Processes. AWWA, Denver, CO, pp. 239-243.
26. Stackelberg, P., Furlong, E., Meyer, M., Zaugg, S., Henderson, A. & Reissman, D. 2004 Persistenece of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking water treatment plant. Sci. Total Environ. 329, 99-113.
27. Ternes, T. A., Janex-Habibi, M. L., Knacker, T., Kreuzinger, N. & Siegrist, H. 2004 Assessment of Technologies for the Removal of Pharmaceuticals and Personal Care Products in Sewage and Drinking Water Facilities to Improve the Indirect Potable Water Reuse (POSEIDON final report, EU project), Wiesbaden, Germany.
28. USEPA 2007 Pharmaceuticals and Personal Care Products. www.epa.gov/esd/chemistry/pharma Website accessed 11th June 2007.
29. Zuccato, E., Castiglioni, S., Fanelli, R., Reitano, G., Bagnati, R., Chiabrando, C., Pomati, F., Rossetti, R. & Calamari, D. 2006 Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control. Environ. Sci. Pollut. Res. 13, 15-21.